In patients with Chediak-Higashi syndrome undergoing allogeneic SCT, does adding etoposide to the conditioning regimen improve the outcome?
Ayas
M
M
Al-Ghonaium
A
A
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D002609:Chediak-Higashi Syndrome / Q000628:therapy*; D005047:Etoposide / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D019172:Transplantation Conditioning / Q000379:methods*; D014184:Transplantation, Homologous
D000972:Antineoplastic Agents, Phytogenic; D005047:Etoposide